• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

OptiScan

7 medtech advances to improve diabetes treatment

January 10, 2020 By Sean Whooley

Medtech and pharmaceutical companies have made several important strides over the past year when it comes to improving diabetes treatment. Multiple treatments and technologies have cleared regulatory hurdles and are now hitting the market and making the process of living with diabetes that much more manageable. Several different styles of therapy and devices have come […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance, Software / IT Tagged With: DarioHealth Corp, FDA, Medtronic, Novo Nordisk, One Drop, OptiScan, popsdiabetescare, Senseonics, tandemdiabetes, Valeritas

Medtronic taps Lennon as CIO | Personnel Moves – April 9, 2018

April 9, 2019 By Fink Densford

Medtronic (NYSE:MDT) said that it named Sean Lennon as its new chief information officer, set to take effect April 29. The Fridley, Minn.-based medtech giant said that Lennon will take over for Mike Hedges, who is retiring from the position after 19 years with Medtronic, including 10 as CIO. Prior to joining Medtronic, Lennon served as […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Allergan, Clearside Biomedical, ICU Medical Inc., iHear Medical, LifeScan Inc., lumenxt, Medtronic, Novartis, OptiScan, oregonbioscienceassociation, Owens and Minor, Shape Memory Therapeutics, SynCardia

OptiScan raises $20m for bedside glucose monitoring system

March 20, 2019 By Sarah Faulkner

OptiScan Biomedical said today that it closed a $20 million Series E round to support the commercialization of its continuous monitoring system, the OptiScanner 5000, in the U.S. The company’s device is an automated bedside blood glucose monitor designed for use in the intensive care unit. The system can measure glucose values from a micro-sample of […]

Filed Under: Business/Financial News, Diabetes, Featured, Funding Roundup, Hospital Care Tagged With: OptiScan

OptiScan taps ex-Hansen Medical chief Vance for CEO | Personnel Moves, May 23, 2018

May 23, 2018 By Brad Perriello

OptiScan taps ex-Hansen Medical chief Vance for CEO OptiScan Biomedical tapped former Myoscience and Hansen Medical chief Cary Vance to be its new CEO, replacing interim head William Mince. “I am excited to join OptiScan at this pivotal point in the company’s growth. I believe that the cutting-edge OptiScanner diagnostic system provides a unique platform […]

Filed Under: Wall Street Beat Tagged With: Clinical Innovations, Dune Medical Devices Inc., Globus Medical, OMNIlife Science Inc., OptiScan, Personnel Moves, SetPoint Medical, Strata Skin Sciences, TrueVision Systems

OptiScan CEO: Glucose monitor approval is biggest advancement for ICU care in 10 years

October 23, 2017 By Sarah Faulkner

Just last week, OptiScan Biomedical announced that its OptiScanner 5000 glucose monitoring system won 510(k) clearance for use in surgical intensive care units. The regulatory win was supported by eight rigorous clinical trials, CEO Peter Rule told Drug Delivery Business News, and represents a victory for a technology that the company hopes to expand into a platform system. Get the […]

Filed Under: 510(k), Diabetes, Food & Drug Administration (FDA), Hospital Care, Patient Monitoring, Regulatory/Compliance Tagged With: OptiScan

OptiScan’s glucose monitoring system for the ICU wins 510(k) clearance

October 18, 2017 By Sarah Faulkner

OptiScan Biomedical said today that its OptiScanner 5000 glucose monitoring system won 510(k) clearance. The device is the first of its kind, providing physicians with trending and tracking information to manage their patients’ blood glucose levels in surgical intensive care units. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: 510(k), Diabetes, Food & Drug Administration (FDA), Hospital Care, Regulatory/Compliance Tagged With: OptiScan

OptiScan wins CE Mark for OptiScanner ICU CGM, lactate monitor

January 9, 2017 By Fink Densford

OptiScan Biomedical said today it won CE Mark approval in the European Union for its OptiScanner 6000 intensive care unit monitor, which includes near-continuous glucose monitoring and serial monitoring of lactate levels. The OptiScanner 6000 is an automated bedside monitor which uses a micro-sample of blood to track glucose and lactate, the San Francisco-based company […]

Filed Under: Diabetes, Diagnostics, Regulatory/Compliance Tagged With: OptiScan

Toshiba increases MR efficiency with M-Power | Regulatory Roundup

September 22, 2011 By MassDevice staff Leave a Comment

Toshiba

Toshiba Medical’s M-Power interface, a customizable MRI system designed to accelerate the scanning process and enhance diagnoses. M-Power will be availble for use on Toshiba’s Vantage Atlas, Vantage Titan, and Titan3T system.

The interface uses a drag and drop method that, Toshiba said, will enhance useability, allowing technicians to favorite the most frequently used scanning tools.

Sign up to get our free newsletters delivered right to your inbox.

Filed Under: News Well Tagged With: Anulex Technologies Inc., Bayer, General Electric, Maquet Cardiovascular LLC, MEDRAD Inc., MedWaves, OptiScan, Regulatory Roundup, Toshiba

OptiScan Biomedical receives CE Mark for OptiScanner automatic bedside glucose monitoring system

September 22, 2011 By MassDevice Leave a Comment

Certification Enables European Sale and Marketing of World’s First Automated Device Designed to Continuously Monitor Glucose Levels in Critically Ill Patients

Filed Under: Uncategorized Tagged With: OptiScan

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS